NRX Pharmaceuticals, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of noncurrent assets classified as other.
Summary: NRX Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2020 to Q3 2024.
NRX Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $356K, a 1595% increase year-over-year.

Other Assets, Noncurrent, Quarterly (USD)

Other Assets, Noncurrent, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$356K	+$335K	+1595%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$384K	+$363K	+1729%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$441K	+$417K	+1738%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$431K	+$410K	+1952%	Dec 31, 2023	10-Q	2024-11-14
Q3 2023	$21K	-$2K	-8.7%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$21K	+$2K	+10.5%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$24K	+$7K	+41.2%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$21K	+$6K	+40%	Dec 31, 2022	10-K	2024-03-29
Q3 2022	$23K	+$7.08K	+44.5%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$19K	+$6.27K	+49.3%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$17K			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$15K	+$4.09K	+37.4%	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$15.9K			Sep 30, 2021	10-Q/A	2022-08-12
Q2 2021	$12.7K			Jun 30, 2021	10-Q/A	2022-08-12
Q4 2020	$10.9K			Dec 31, 2020	10-Q/A	2022-08-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.